Page last updated: 2024-09-05

etravirine and Central Nervous System Diseases

etravirine has been researched along with Central Nervous System Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, M; Garvey, L; Hadley, W; Higgs, C; Mandalia, S; Nelson, M; Nicola, M; Perry, N; Waters, L; Winston, A	1

Trials

1 trial(s) available for etravirine and Central Nervous System Diseases

Article	Year
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine. AIDS (London, England), 2011, Jan-02, Volume: 25, Issue:1 Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Central Nervous System Diseases; Cyclopropanes; Feasibility Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Nitriles; Pilot Projects; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Viral Load	2011

Article

Year

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

AIDS (London, England), 2011, Jan-02, Volume: 25, Issue:1

Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Central Nervous System Diseases; Cyclopropanes; Feasibility Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Nitriles; Pilot Projects; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Viral Load

2011